HNF4A and colorectal carcinoma: FH535 is a small molecule and dual inhibitor of β-catenin/TCF and PPARs, which has been demonstrated to selectively inhibit the proliferation of pancreatic, hepatocellular, breast, and colorectal carcinoma cells (41).